Descemet Membrane Endothelial Keratoplasty and Bowman Layer Transplantation: An Anatomic Review and Historical Survey.

Bowman layer transplantation Corneal endothelial dysfunction Corneal transplantation Descemet membrane endothelial keratoplasty Keratoconus

Journal

Ophthalmic research
ISSN: 1423-0259
Titre abrégé: Ophthalmic Res
Pays: Switzerland
ID NLM: 0267442

Informations de publication

Date de publication:
2021
Historique:
received: 10 12 2020
accepted: 23 03 2021
pubmed: 25 3 2021
medline: 15 2 2022
entrez: 24 3 2021
Statut: ppublish

Résumé

For nearly a century, the definitive treatment of many corneal dystrophies and ectactic disorders was limited to penetrating keratoplasty, but over the past 2 decades, a surge of surgical innovation has propelled the treatment of many corneal diseases to more targeted approaches with significantly better visual outcomes. Anterior stromal diseases were first changed through endothelial-sparing techniques, such as deep anterior lamellar keratoplasty, but have more recently transitioned to stromal-sparing approaches. Ultraviolet corneal crosslinking strengthens the cornea and halts progression of keratoconus in >90% of cases. Intracorneal ring segment and corneal allogenic ring segment implantation offer methods to flatten ectatic corneas. However, Bowman layer transplantation - inlay and more recently onlay techniques - has shown promise for treating advanced keratoconus and preventing keratoplasty. The advent of endothelial keratoplasty radically changed the treatment of corneal endothelial dysfunction, and Descemet membrane endothelial keratoplasty specifically offers an average postoperative visual acuity of 20/25 (0.8) with only 8.8% of grafts requiring retransplantation in the first 5 years. Here, we review the rapid innovations for surgical treatment of corneal diseases, spanning from endothelial keratoplasty and endothelial regeneration to anterior lamellar keratoplasty and stromal augmentation, highlighting key steps which may be moving us closer to a "postkeratoplasty" world.

Identifiants

pubmed: 33761502
pii: 000516093
doi: 10.1159/000516093
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

532-553

Informations de copyright

© 2021 The Author(s) Published by S. Karger AG, Basel.

Auteurs

Jack Parker (J)

Parker Cornea, Birmingham, Alabama, USA.
Netherlands Institute for Innovative Ocular Surgery- USA (NIIOS-USA), San Diego, California, USA.

Philip Dockery (P)

Parker Cornea, Birmingham, Alabama, USA.
Wills Eye Hospital, Philadelphia, Pennsylvania, USA.

Ana Preda-Naumescu (A)

University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.

Martine Jager (M)

Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Korine van Dijk (K)

Netherlands Institute for Innovative Ocular Surgery (NIIOS), Rotterdam, The Netherlands.
Melles Cornea Clinic Rotterdam, Rotterdam, The Netherlands.

Isabel Dapena (I)

Netherlands Institute for Innovative Ocular Surgery (NIIOS), Rotterdam, The Netherlands.
Melles Cornea Clinic Rotterdam, Rotterdam, The Netherlands.

Gerrit Melles (G)

Parker Cornea, Birmingham, Alabama, USA.
Netherlands Institute for Innovative Ocular Surgery (NIIOS), Rotterdam, The Netherlands.
Melles Cornea Clinic Rotterdam, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH